The Latest Breaking News from FDA

The tool, from telehealth company Ro, lets users report when they find the drug in stock and when there’s a shortage.

Government lawyers had told the court flights could go in late June – but then Rishi Sunak called the election

Helpful tool or harmful fad?

The pharma sector is primed for solid growth owing to technological advancements, growing healthcare needs, and a rise in chronic diseases. Given this backdrop, let’s analyze the fundamentals of pharmaceutical stocks Pfizer (PFE) and Bristol-Myers Squibb (BMY) to determine which of these stocks offer better dividend stability and growth. Read…

“The singular most effective and consistent way of extending lifespan in animals is caloric restriction.”

The first paralysed man with a Neuralink chip reports success (racing games!), but software updates and brain response pose challenges.

Under the proposed law, people found in possession of the pills could face up to five years behind bars

Cathie Wood splurged millions in biotech this year on strong clinical progress, AI adoption, sales growth, wider outreach, and steady product pipelines.

In The Good Doctor series finale, Shaun must make hard choices to save two of his dear friends. We break down what happened.

There's an easy way to lower the cost of next-generation weight-loss drugs.

It looks like Attorney General Merrick Garland overrode the agency's recalcitrant drug warriors in deciding to reclassify the drug.